Evidence map›Paper›PMID 38542079›Full record

ArticleInternational journal of molecular sciences2024

The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer.

Martín Salamini-Montemurri, Ángel Vizoso-Vázquez, Aida Barreiro-Alonso, Lidia Lorenzo-Catoira, Esther Rodríguez-Belmonte, María-Esperanza Cerdán, Mónica Lamas-Maceiras

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Martín Salamini-MontemurriCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.ORCID 0000-0002-0149-5493
Ángel Vizoso-VázquezCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.ORCID 0000-0001-7310-2102
Aida Barreiro-AlonsoCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.
Lidia Lorenzo-CatoiraCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.
Esther Rodríguez-BelmonteCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.ORCID 0000-0001-8243-1303
María-Esperanza CerdánCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.ORCID 0000-0001-8540-1417
Mónica Lamas-MaceirasCentro Interdisciplinar de Química e Bioloxía (CICA), Campus de Elviña, Universidade da Coruña, As Carballeiras, s/n, 15071 A Coruña, Spain.ORCID 0000-0001-8025-2838
Universidade da Coruña · ES

Funding

Instituto de Salud Carlos III PI18/01417and Fortalece FORT23/00010Ministerio de Ciencia e Innovación PID2021-124564OB-I00The European Regional Development Fund-ERDF cofunded PI18/01417, PID2021-124564OB-I00, ED431C 2020-08Xunta de Galicia ED431C 2020-08
6 · The paper itself

Abstract

Human high-mobility group-B (HMGB) proteins regulate gene expression in prostate cancer (PCa), a leading cause of oncological death in men. Their role in aggressive PCa cancers, which do not respond to hormonal treatment, was analyzed. The effects of

Indexed as

AdenocarcinomaHMGB1 ProteinProstatic NeoplasmsCell LineHMGB2 ProteinHumansMaleTranscription FactorsHMGB1 ProteinHMGB1 protein, humanHMGB2 ProteinTranscription FactorsCDK1FN1HMGB proteinsIGBPB3neuroendocrine prostatic cancerSERPINE1transcriptional regulationTYMSZWINT

Identifiers

PMID38542079
PMCPMC10969884
OpenAlexW4392561605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.